WNT6 and glioblastoma: Silencing of WNT6 in GBM cells significantly decreases their capacity to form neurospheres and increases sensitivity to temozolomide (TMZ), leading to decreased tumor aggressiveness in vivo and prolonged overall survival in mice [127].